Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 5, 2016 |
| Target | Soluble Systems |
| Sector | Medical Products |
| Buyer(s) | Alliqua |
| Deal Type | Add-on Acquisition |
| Deal Value | 35M USD |
| Advisor(s) | Canaccord Genuity (Financial) |
FILTER BY
| Category | Company |
|---|---|
| Sector | Medical Products |
| Revenue | 2M USD (2018) |
Alliqua provides a custom manufacturing solution to partners in the medical device; cosmetics; and OTC industry, utilizing its proprietary hydrogel technology. Alliqua's electron beam production process, located at its 16,500 square foot GMP manufacturing facility in Langhorne, Pa., allows Alliqua to custom manufacture a wide variety of hydrogels. Alliqua's hydrogels can be customized for various transdermal applications to address market opportunities in the treatment of wounds as well as the delivery of numerous drugs or other agents for the pharmaceutical and cosmetic industries.
| Deal Context for Buyer | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Medical Products | 3 of 3 |
| Type: Add-on Acquisition | 3 of 3 |
| State: Virginia | 1 of 1 |
| Country: United States | 3 of 3 |
| Year: 2016 | 1 of 1 |
| Size (of disclosed) | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-02-02 |
Celleration
Eden Prairie, Minnesota, United States Celleration, Inc. is a privately held medical device company. Celleration develops and markets a proprietary technology that has been proven to accelerate healing in wounds by delivering therapeutic, low frequency ultrasound without direct contact of the delivery device to the wound surface. Celleration's core product, the MIST Therapy System, has been clinically shown to positively impact all critical aspects of the wound healing process providing clinical and economic benefits to institutions treating nonresponding wounds. |
Buy | $30M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-09-05 |
TheraBond
Yardley, Pennsylvania, United States The TheraBond® product line is based on a proprietary and patented manufacturing process where silver is bonded to the entire surface of all fibers of the TheraBond® dressing. When TheraBond® products are placed on the wound, bioactive ionic silver is released in the dressing at a controlled rate, promoting an optimal wound healing environment by creating an antimicrobial barrier to more effectively protect the wound. |
Sell | $4M |
